1,027 material Form 8-K filings that 835 companies we cover made with the SEC in February 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
HP Inc. elected Songyee Yoon, a venture capital managing partner, as an independent director effective February 6, 2025, and appointed her to the Audit Committee and Finance, Investment and Technology Committee. The Board also amended the bylaws to increase authorized board seats from 13 to 14 to accommodate her appointment.
Songyee Yoon elected director effective February 6, 2025; board authorized seats rise from 13 to 14
Yoon named to Audit Committee and Finance, Investment and Technology Committee, effective February 6, 2025
Non-employee directors receive a $105,000 annual cash retainer and a $220,000 annual equity retainer; Yoon's first year is pro-rated
Arrowhead appointed Douglas Ingram, President and CEO of Sarepta Therapeutics, as a director effective February 6, 2025, under an Investor Rights Agreement with Sarepta. The filing ties the appointment to the Collaboration Agreement and Stock Purchase Agreement with Sarepta, which the filing says closed on February 7, 2025, and makes Mr. Ingram not independent under Nasdaq rules.
Douglas Ingram appointed director effective February 6, 2025; appointment made under Investor Rights Agreement with Sarepta dated November 25, 2024
Sign-on grant of restricted stock units valued at $771,200, scheduled to vest over three years
Mr. Ingram is President and CEO of Sarepta; the Collaboration and Stock Purchase Agreements with Sarepta closed February 7, 2025
Filing states Mr. Ingram is not considered an independent director under Nasdaq Listing Rules
Black Hills Corporation disclosed that Senior Vice President and Chief Information Officer Erik Keller intends to resign, effective February 28, 2025. The filing does not state a successor or any financial impact, so the change appears to be an executive departure with limited direct consequences for shareholders.
Erik Keller announced his intention to resign as Senior Vice President and Chief Information Officer on January 31, 2025.
Resignation is effective February 28, 2025.
The filing does not name a successor or describe any compensation arrangements.
Valero Energy entered into an underwriting agreement on February 4, 2025, to issue $650 million of 5.150% senior notes due 2030 under a registered shelf. The sale is expected to close on February 7, 2025. The filing adds debt to the company's balance sheet, but it does not disclose how the proceeds will be used.
Principal amount: $650 million of 5.150% senior notes due 2030
Underwriters include Citigroup, BofA Securities, J.P. Morgan and Mizuho Securities as representatives
AptarGroup reported fourth-quarter 2024 net income of $101 million, up 62%, with reported sales up 1% to $848 million and core sales up 2%. The company guided first-quarter 2025 adjusted EPS to $1.11 to $1.19, below the $1.19 adjusted EPS it reported for the first quarter of 2024, citing an expected currency headwind of about 7 cents and a higher tax rate.
Q4 2024 diluted EPS was $1.49 vs $0.93 a year earlier; adjusted EPS was $1.52, up 27%
Q4 reported sales rose 1% to $848 million; core sales rose 2%, with currency a negative effect
Q1 2025 adjusted EPS guidance of $1.11 to $1.19 vs $1.19 adjusted in Q1 2024; FX headwind of about 7 cents
Board approved a $0.45 quarterly dividend payable February 26, 2025 and a $500 million share repurchase authorization
Post Holdings reported first-quarter fiscal 2025 results for the period ended December 31, 2024, with net sales of $1,974.7 million, up 0.4%, and net earnings of $113.3 million, up 28.6%. The company raised its fiscal 2025 Adjusted EBITDA outlook to $1,420-$1,460 million from $1,410-$1,460 million and approved a new $500 million share repurchase authorization effective February 10, 2025, which replaces the existing program.
Net sales were $1,974.7 million, up 0.4% from $1,965.9 million; diluted EPS was $1.78 versus $1.35 a year earlier
Adjusted diluted EPS was $1.73 versus $1.69; Adjusted net earnings were $111.9 million versus $113.7 million
Fiscal 2025 Adjusted EBITDA outlook raised to $1,420-$1,460 million from $1,410-$1,460 million
New $500 million buyback approved February 4, 2025; $200.2 million remained under the existing authorization as of February 6, 2025, which will be cancelled February 9, 2025
Minerals Technologies reported fourth-quarter and full-year 2024 results in a press release furnished under Item 2.02 of a Form 8-K dated February 6, 2025. Fourth-quarter net sales slipped 1% to $518.1 million while diluted EPS rose to $1.68 from $1.22, and full-year net sales fell 2% to $2.12 billion while diluted EPS more than doubled to $5.17 from $2.58. The filing does not include forward guidance, and the company will discuss the results on a conference call on February 7, 2025.
Q4 2024 net sales were $518.1 million, down 1% from $524.5 million in Q4 2023.
Q4 diluted EPS was $1.68 versus $1.22; excluding special items, it was $1.50 versus $1.28.
Full-year 2024 net sales were $2.12 billion, down 2%; diluted EPS was $5.17 versus $2.58, or $6.15 versus $5.21 excluding special items.
In 2024 the company repurchased $64 million of shares and repaid $39 million of debt.
Arcus Biosciences reported that Merdad Parsey resigned from its Board of Directors on February 6, 2025, in connection with his departure from Gilead Sciences. The Board the same day appointed Dietmar Berger, who joined Gilead in January 2025 as its Chief Medical Officer, as a Class II director to fill the vacancy; the filing says Gilead's board designee arrangement governs the timing of the change.
Merdad Parsey resigned from the Arcus Board, effective upon appointment of Gilead's new director designee under the Amended and Restated Investor Rights Agreement dated January 29, 2024.
Dietmar Berger was appointed as a Class II director on February 6, 2025.
Dr. Berger will receive no compensation for Board service; Arcus expects to enter its standard indemnification agreement with him.
CNO Financial Group reported fourth-quarter 2024 net income of $166.1 million, or $1.58 per diluted share, up from $36.3 million, or $0.32, a year earlier. Net operating income, which excludes non-economic market-volatility accounting impacts, rose to $138.0 million, or $1.31 per diluted share, from $133.9 million, or $1.18. For shareholders, full-year 2024 net income was $404.0 million, or $3.74 per diluted share, versus $276.5 million, or $2.40, in 2023, and the company returned $349.3 million to shareholders during the year.
4Q24 net income $166.1 million, $1.58 per diluted share, versus $36.3 million, $0.32 in 4Q23
4Q24 net operating income $138.0 million, $1.31 per diluted share, versus $133.9 million, $1.18 in 4Q23
Full-year 2024 net income $404.0 million, $3.74 per diluted share, versus $276.5 million, $2.40 in 2023
Returned $349.3 million to shareholders in 2024; $240.3 million of repurchase authority remained at December 31, 2024
Korn Ferry disclosed that Mark Arian, its Chief Executive Officer, Consulting, died on February 6, 2025. The company named Lesley Uren, previously President of Consulting in EMEA for three years, to take over the role effective February 6, 2025. The change affects a leadership role in one of the company's business lines, and the filing does not discuss any financial impact.
Mark Arian, CEO, Consulting, passed away on February 6, 2025
Lesley Uren appointed CEO, Consulting, effective February 6, 2025
Uren previously served as President of Consulting in EMEA for the past three years
Filing states the company expects a seamless transition; no financial figures disclosed
Globus Medical agreed to acquire Nevro Corp. in an all-cash transaction valued at approximately $250 million in total equity value, subject to Nevro shareholder approval, regulatory clearance and other closing conditions. Globus Medical said that after the deal closes it expects higher 2025 net sales but lower non-GAAP earnings per share than its stand-alone guidance.
Nevro shareholders will receive $5.85 per share in cash, a 17% premium to Nevro's February 5, 2025 closing price.
Globus Medical expects the deal to close late in the second quarter of 2025 and anticipates the Nevro acquisition to be accretive to earnings in the second year of operation.
Post-deal 2025 guidance: net sales of $2.80 billion to $2.90 billion (versus stand-alone $2.66 billion to $2.69 billion) and non-GAAP EPS of $3.10 to $3.40 (versus stand-alone $3.40 to $3.50).
Termination fees: Nevro would pay $15 million or $10 million in certain circumstances, including a failed stockholder vote; Globus Medical would pay $15 million in certain circumstances.
Cleveland-Cliffs issued $850 million of 7.500% senior guaranteed notes maturing September 15, 2031, in a private transaction, under an indenture dated February 6, 2025. The company intends to use the net proceeds for general corporate purposes, including repaying borrowings under its asset-based credit facility, which adds long-term debt while refinancing shorter-term borrowings.
Principal amount: $850 million; interest rate 7.500%, paid semi-annually on March 15 and September 15, starting September 15, 2025
Notes mature September 15, 2031; issued February 6, 2025 to U.S. Bank Trust Company, National Association, as trustee
Company may redeem before March 15, 2028 at par plus a make-whole premium, and from March 15, 2028 at an initial 103.750% price
Net proceeds intended for general corporate purposes, including repayment of asset-based credit facility borrowings
Principal Financial Group reported fourth-quarter and full-year 2024 results, with GAAP net income of $905.4 million in the quarter versus a $871.7 million loss a year earlier. It also raised its first-quarter 2025 dividend to $0.75 per share and approved a new $1.5 billion share repurchase authorization, while its 2025 outlook is consistent with long-term targets of 9-12% non-GAAP operating EPS growth.
4Q24 GAAP net income attributable to PFG was $905.4 million, or $3.92 per diluted share, compared with a loss of $871.7 million, or $3.66 per share, in 4Q23
4Q24 non-GAAP operating earnings per diluted share were $1.94, up 6% from $1.83; full-year 2024 was $7.65 excluding significant variances, up 11%
Quarterly dividend raised to $0.75 per share, payable March 28, 2025, to shareholders of record as of March 12, 2025
Board approved a new $1.5 billion share repurchase authorization; about $0.8 billion remained under the prior authorization at December 31, 2024
Regency Centers reported fourth-quarter and full-year 2024 results and gave initial 2025 guidance. Nareit FFO per diluted share rose to $1.09 in the fourth quarter from $1.02 a year earlier, while net income per diluted share slipped to $0.46 from $0.47, including a $14.3 million impairment charge. The company guided to 2025 Core Operating Earnings of $4.30 to $4.36 per share, above the $4.13 reported for 2024.
Q4 2024 Nareit FFO was $199.5 million, or $1.09 per diluted share, versus $1.02 in Q4 2023; full-year 2024 Nareit FFO was $4.30 per share.
Q4 2024 net income attributable to common shareholders was $83.1 million, or $0.46 per diluted share, versus $0.47 a year earlier; the quarter included a $14.3 million impairment charge.
2025 guidance: Nareit FFO of $4.52 to $4.58 per diluted share and Core Operating Earnings of $4.30 to $4.36, compared with 2024 actuals of $4.30 and $4.13.
Same Property percent leased reached a record 96.7% at December 31, 2024; the quarterly common dividend declared February 4, 2025 is $0.705 per share.
Victory Capital reported fourth-quarter 2024 revenue of $232.4 million, up 12.9% from a year earlier, and GAAP net income of $76.9 million, or $1.17 per diluted share, up 39.4% from $55.2 million. Compared with the third quarter, net income fell 6.2%, and the company cited a $15.6 million increase in compensation-related expenses. The board also approved a new $200 million share repurchase plan and a 7% increase in the quarterly dividend to $0.47 per share.
Q4 2024 revenue $232.4 million, up 12.9% from $205.8 million in Q4 2023
GAAP diluted EPS $1.17 for Q4 2024, versus $0.82 in Q4 2023 and $1.24 in Q3 2024
Adjusted net income with tax benefit per diluted share $1.45, versus $1.15 a year earlier
New $200 million share repurchase plan; quarterly dividend raised to $0.47, payable March 10, 2025
On February 4, 2025, Sprinklr committed to a reduction in force affecting about 15% of its global workforce as of January 31, 2025, which it says will realign employee costs with the current business and free up capital for investments in go-to-market and R&D resources. The company estimates about $25 million in non-recurring charges, mostly in the first and second quarters of fiscal 2026. It also expects its results for the quarter and fiscal year ended January 31, 2025 to be in line with or above its December 4, 2024 guidance, with formal guidance to come at its March 2025 earnings call.
Reduction in force of about 15% of global workforce, committed February 4, 2025
Estimated non-recurring charges of about $25 million, mostly in Q1 and Q2 of fiscal 2026
Preliminary quarter and fiscal year ended January 31, 2025 results expected in line with or above December 4, 2024 guidance
Formal guidance for quarter ending April 30, 2025 and fiscal 2026 to be provided at March 2025 earnings call
Powell Industries reported first quarter fiscal 2025 results for the period ended December 31, 2024, with revenue up 24% from the prior year and diluted earnings per share of $2.86, up from $1.98. Net income rose 44% to $34.8 million, and new orders grew to $269 million, though revenue and profit both fell sequentially from the fourth quarter, which the company attributed mainly to seasonality. Management said it expects robust revenue and earnings through the rest of fiscal 2025.
Revenue of $241.4 million, up 24% year over year but down 12% from $275.1 million in the fourth quarter of fiscal 2024
Net income of $34.8 million, or $2.86 per diluted share, up 44% from $1.98 a year earlier
New orders of $269 million versus $198 million a year earlier; backlog steady at $1.3 billion
Conference call scheduled for February 7, 2025 at 11:00 a.m. Eastern time
Encompass Health reported fourth-quarter 2024 net operating revenue of $1,405.0 million, up 12.7%, and diluted earnings per share from continuing operations of $1.18, up from $0.94 a year earlier. The company also issued 2025 guidance for net operating revenue of $5,800 million to $5,900 million, Adjusted EBITDA of $1,160 million to $1,200 million, and adjusted earnings per share of $4.67 to $4.96.
Q4 2024 net operating revenue was $1,405.0 million, up from $1,246.8 million; diluted EPS from continuing operations was $1.18 versus $0.94
Q4 2024 Adjusted EBITDA was $289.6 million, up 13.6%; adjusted EPS was $1.17 versus $0.95
2025 guidance: net operating revenue $5,800 million to $5,900 million; Adjusted EBITDA $1,160 million to $1,200 million; adjusted EPS $4.67 to $4.96
Management will discuss results on an earnings call at 10:00 a.m. Eastern Time on February 7, 2025
COPT Defense Properties reported fourth-quarter and full-year 2024 results in an earnings release furnished as Exhibit 99.1. Full-year net income was $143.9 million, compared with a net loss of $74.3 million in 2023, which included impairment losses on real estate, and revenue rose to $753.3 million from $685.0 million.
Q4 2024 FFO per diluted share was $0.64, up from $0.62 in Q4 2023; full-year FFO per diluted share was $2.57, up from $2.41.
Q4 2024 diluted EPS was $0.31, compared with $0.30 in Q4 2023; full-year 2024 diluted EPS was $1.23, compared with a loss of $0.67 in 2023.
Q4 2024 total revenues were $183.4 million, up from $179.7 million; quarterly dividend per share was $0.295, up from $0.285.
Q4 2024 diluted AFFO was $47.9 million, down from $54.3 million in Q4 2023, while full-year diluted AFFO rose to $222.2 million from $203.0 million.
Lumentum reported fiscal second quarter 2025 net revenue of $402.2 million, up 19.4% from the prior quarter and 9.7% from a year earlier, with GAAP net loss narrowing to $60.9 million, or $0.88 per diluted share. It guided fiscal third quarter net revenue to $410 million to $425 million and non-GAAP diluted EPS to $0.47 to $0.53, and said CEO Alan Lowe will transition to Michael Hurlston.
Q2 net revenue $402.2 million vs. $336.9 million in Q1 and $366.8 million in Q2 2024
GAAP net loss $60.9 million ($0.88 per diluted share) vs. $82.4 million in Q1 and $99.1 million in Q2 2024
Q3 fiscal 2025 outlook: net revenue $410 million to $425 million; non-GAAP diluted EPS $0.47 to $0.53
Cash, cash equivalents and short-term investments were $896.7 million, down $19.4 million from Q1
Cousins Properties reported fourth-quarter 2024 results on February 6, 2025. Funds from operations (FFO) rose to $108.9 million, or $0.69 per share, from $98.3 million, or $0.65 per share, a year earlier, while net income available to common stockholders fell to $13.6 million, or $0.09 per share, from $18.8 million, or $0.12 per share, which the company attributed mainly to higher depreciation. The company also gave initial 2025 guidance of FFO between $2.73 and $2.83 per share.
Q4 2024 FFO was $108.9 million, or $0.69 per share, versus $98.3 million, or $0.65 per share, in Q4 2023.
Q4 2024 net income available to common stockholders was $13.6 million, or $0.09 per share, versus $18.8 million, or $0.12 per share.
Full-year 2024 FFO was $414.1 million, or $2.69 per share, versus $398.3 million, or $2.62 per share, in 2023.
2025 guidance: net income of $0.25 to $0.35 per share and FFO of $2.73 to $2.83 per share.
Mohawk Industries reported fourth-quarter 2024 net sales of $2.6 billion, up 1.0% as reported but down 1.0% on an adjusted basis, and diluted EPS of $1.48 versus $2.18 a year earlier. Adjusted EPS was $1.95 versus $1.96, and the company expects first-quarter 2025 adjusted EPS of $1.34 to $1.44, including a $0.35 impact from order management system problems in its Flooring North America segment.
Q4 2024 net earnings were $93 million, or $1.48 per diluted share, compared with $140 million, or $2.18, in Q4 2023; adjusted diluted EPS was $1.95 versus $1.96.
Full-year 2024 diluted EPS was $8.14 versus a loss of $6.90 in 2023, which included $878 million of impairment charges; full-year adjusted EPS of $9.70 rose about 6%.
First-quarter 2025 adjusted EPS is expected between $1.34 and $1.44, with the company citing ongoing softness in all markets and a $0.35 EPS impact from system issues.
Free cash flow for 2024 was $680 million and the company repurchased 1.3 million shares for $161 million.
ESCO reported fiscal first-quarter 2025 sales of $247.0 million, up 13.2%, and GAAP EPS of $0.91 versus $0.59 a year earlier. The company raised its full-year fiscal 2025 adjusted EPS guidance to $5.55 to $5.75 from $5.30 to $5.50, though it now excludes acquisition-related amortization from adjusted EPS. The filing also covered the annual meeting, where directors and executive pay were approved, and a board reduction from nine to eight directors.
Q1 fiscal 2025 sales were $247.0 million, up from $218.3 million; GAAP EPS was $0.91 versus $0.59.
Adjusted EPS excluding acquisition-related amortization was $1.07, up 41% from $0.76 a year earlier.
Full-year fiscal 2025 adjusted EPS guidance raised by $0.25 to $5.55 to $5.75; Q2 adjusted EPS guidance is $1.20 to $1.30.
Pending $550 million SM&P acquisition; US closing conditions met, UK review in final stages. Board size cut to eight after Leon J. Olivier retired.
Advance Auto Parts said Executive Vice President, General Counsel and Corporate Secretary Tammy M. Finley is leaving to retire. She is expected to serve in an advisory capacity through May 2, 2025 to support the transition, and her separation triggered a termination without due cause payment under her employment agreement. The filing does not name a successor or give the payment amount.
Tammy M. Finley, EVP, General Counsel and Corporate Secretary, is leaving to begin retirement
Advisory role effective March 2, 2025, through May 2, 2025
Separation triggered a termination without due cause payment under her employment agreement; amount not stated
Company cites more than 25 years of service in legal and human resources functions
Simon Property Group disclosed that Herbert Simon, a co-founder, Chairman Emeritus and director, retired from its Board of Directors effective February 4, 2025, at age 90. The company said the retirement was not due to any disagreement on its operations, policies or practices, and David Simon, Chairman and CEO, thanked him for his contributions.
Herbert Simon, age 90, retired from the Board and his Chairman Emeritus role effective February 4, 2025
The company said the retirement was not due to a disagreement on operations, policies or practices
David Simon, Chairman, CEO and President, credited Herbert Simon's knowledge and experience as a co-founder
Allegro MicroSystems entered into Amendment No. 3 to its credit agreement, creating a new $375 million tranche of term loans maturing October 31, 2030. The proceeds will refinance existing Amendment No. 2 term loans, pay related fees and expenses, and fund general corporate purposes, so the company is replacing existing borrowing rather than announcing a new spending plan.
New $375 million term loan tranche maturing October 31, 2030
Loans amortize at 0.00% per annum and bear interest at Term SOFR plus 2.00%, or an alternate base rate option
Proceeds will refinance all outstanding Amendment No. 2 term loans, pay fees, and fund general corporate purposes
Amendment No. 3 dated February 6, 2025, filed as Exhibit 10.1
EastGroup Properties reported fourth-quarter 2024 diluted EPS of $1.16, down from $1.35 a year earlier, mainly because the 2023 quarter included $13 million in property sale gains and there were no sales in the 2024 quarter. Funds from operations (FFO) excluding gains on involuntary conversion and business interruption claims rose 5.9% to $2.15 per diluted share, and the company set 2025 guidance of $8.80 to $9.00 in FFO per share.
Q4 2024 diluted EPS was $1.16 versus $1.35 in Q4 2023; the 2023 quarter included $13 million in real estate sale gains and there were no sales in Q4 2024.
Q4 2024 FFO excluding certain claim gains was $2.15 per diluted share versus $2.03, an increase of 5.9%.
Full-year 2024 diluted EPS was $4.66 versus $4.42, and FFO excluding certain claim gains was $8.31 versus $7.70, an increase of 7.9%.
2025 guidance calls for EPS of $4.71 to $4.91 and FFO of $8.80 to $9.00 per diluted share.
Genpact reported full-year 2024 net revenues of $4.77 billion, up 6.5%, and adjusted diluted EPS of $3.28, up 10%. GAAP diluted EPS fell 16% to $2.85 and net income fell 19% to $514 million, with the 2023 comparison including a $170 million non-recurring tax benefit. The company also raised its quarterly dividend 11% to $0.17 and added $500 million to its share repurchase authorization, and it guided to 2025 adjusted diluted EPS of $3.52 to $3.59.
Full-year 2024 net revenues were $4.77 billion, up 6.5%; fourth-quarter net revenues were $1.25 billion, up 8.9%
Diluted EPS was $2.85, down 16%; adjusted diluted EPS was $3.28, up 10%
2025 outlook: net revenues of $5.029 billion to $5.125 billion and adjusted diluted EPS of $3.52 to $3.59
Quarterly dividend raised to $0.17 per share (11% increase), payable March 26, 2025; repurchase authorization increased by $500 million
QuinStreet reported record fiscal second quarter 2025 revenue of $282.6 million for the quarter ended December 31, 2024, up 130% year-over-year, and posted a GAAP net loss of $1.5 million, or $0.03 per diluted share. The company raised its full fiscal 2025 outlook, now expecting revenue of $1.065 billion to $1.105 billion and Adjusted EBITDA of $80 million to $85 million.
Q2 revenue was $282.6 million, up 130% year-over-year, with Auto Insurance revenue up 615% and non-insurance revenue up 15%.
GAAP net loss narrowed to $1.5 million, or $0.03 per diluted share, from a net loss of $11.6 million a year earlier; adjusted net income was $11.9 million, or $0.20 per diluted share.
Adjusted EBITDA was $19.4 million for the quarter, compared with $417 thousand a year earlier.
For fiscal Q3, the company expects revenue of $265 million to $275 million and Adjusted EBITDA of $19.5 million to $20.0 million.
For the fiscal third quarter ended December 31, 2024, Take-Two reported net bookings of $1.37 billion, up 3% from $1.34 billion a year earlier, while GAAP net revenue was $1.36 billion, down from $1.37 billion. The GAAP net loss widened to $125.2 million, or $0.71 per share, from $91.6 million, or $0.54 per share, and the company reiterated its fiscal 2025 net bookings guidance of $5.55 billion to $5.65 billion. Shareholders are weighing bookings growth against a larger loss and slightly lower revenue.
Net bookings were $1.37 billion, up 3% from $1.34 billion; recurrent consumer spending grew 9%.
GAAP net revenue was $1.36 billion, compared with $1.37 billion in the prior-year quarter.
GAAP net loss was $125.2 million, or $0.71 per share, versus $91.6 million, or $0.54 per share, a year earlier.
Fiscal 2025 net bookings guidance was reiterated at $5.55 billion to $5.65 billion; fiscal fourth-quarter net bookings outlook is $1.484 billion to $1.584 billion.
NMI Holdings reported fourth-quarter 2024 net income of $86.2 million, or $1.07 per diluted share, up from $83.4 million and $1.01 a year earlier but down from $92.8 million and $1.15 in the third quarter. Full-year 2024 net income rose to $360.1 million, or $4.43 per diluted share, from $322.1 million, or $3.84, in 2023, and the board authorized an additional $250 million share repurchase through December 31, 2027.
Q4 2024 net income $86.2 million, $1.07 per diluted share, vs. $83.4 million, $1.01 in Q4 2023 and $92.8 million, $1.15 in Q3 2024
Full-year 2024 net income $360.1 million, $4.43 per diluted share, vs. $322.1 million, $3.84 in 2023; adjusted diluted EPS $4.50
Q4 2024 loss ratio 12.0%, up from 6.2% a year earlier and 7.2% in Q3 2024; total revenue $166.5 million
Board authorized an additional $250 million share repurchase plan effective through December 31, 2027
Block, Inc. increased its Board from nine to ten directors and elected Anthony Eisen as a Class III director, effective February 6, 2025. Eisen co-founded Afterpay, which Block acquired in 2022, and he is not expected to serve on any Board committees at this time.
Board size increased from nine to ten directors; Anthony Eisen elected as a Class III director effective February 6, 2025.
Eisen co-founded Afterpay in November 2014 and served as its co-CEO; he was Block's co-lead of Afterpay from January 2022 to November 2024.
Eisen has been CEO of privately held Reshop since January 2025 and serves as its Chairman.
Eisen will receive standard non-employee director compensation and has executed Block's standard indemnification agreement.
Fortinet reported fourth-quarter 2024 revenue of $1.66 billion, up 17.3% from a year earlier, and GAAP diluted EPS of $0.68 versus $0.40. It also issued 2025 revenue guidance of $6.650 billion to $6.850 billion, compared with full-year 2024 revenue of $5.96 billion. Chief Financial Officer Keith Jensen plans to retire on May 15, 2025, and Chief Accounting Officer Christiane Ohlgart is expected to succeed him, which shareholders may watch during the transition.
Q4 2024 revenue was $1.66 billion, up 17.3% from $1.42 billion; GAAP net income was $526.2 million.
GAAP diluted EPS was $0.68 for Q4 2024, compared with $0.40 a year earlier.
2025 guidance: revenue of $6.650 billion to $6.850 billion; Q1 2025 revenue of $1.500 billion to $1.560 billion.
Keith Jensen, 66, will retire May 15, 2025 and remain in service through June 30, 2025; Christiane Ohlgart is set to become CFO.
Phillips Edison & Company reported fourth quarter and full-year 2024 results and issued 2025 guidance. Fourth quarter net income attributable to stockholders rose to $18.1 million, or $0.15 per diluted share, from $13.5 million, or $0.11, a year earlier, and full-year Core FFO per share reached $2.43, up 3.8%. For 2025, the company guided Core FFO per share to $2.52 to $2.59, which it says represents 5.1% growth at the midpoint, and gross acquisitions of $350 million to $450 million.
Q4 2024 net income attributable to stockholders was $18.1 million, or $0.15 per diluted share, versus $13.5 million, or $0.11, in Q4 2023.
Q4 2024 Core FFO was $85.8 million, or $0.62 per diluted share, up 10.2%; full-year Core FFO was $2.43 per diluted share, up 3.8%.
2025 guidance: Core FFO per share $2.52 to $2.59; Nareit FFO per share $2.47 to $2.54; net income per share $0.54 to $0.59.
Conference call and webcast set for Friday, February 7, 2025, at 12:00 p.m. Eastern Time.
VeriSign reported fourth-quarter 2024 revenue of $395 million, up 3.9%, but net income fell to $191 million from $265 million, and diluted EPS fell to $2.00 from $2.60. The prior-year quarter included a $69.3 million income tax benefit. For full-year 2024, revenue rose 4.3% to $1.56 billion and diluted EPS rose to $8.00 from $7.90, while net income declined to $786 million from $818 million.
Q4 2024 revenue $395 million, up 3.9% from Q4 2023; Q4 operating income $264 million vs. $256 million
Q4 2024 net income $191 million and diluted EPS $2.00, vs. $265 million and $2.60 in Q4 2023, which included a $69.3 million tax benefit
Full-year 2024 revenue $1.56 billion, up 4.3%; diluted EPS $8.00 vs. $7.90; net income $786 million vs. $818 million
Full-year 2024 share repurchases totaled $1.21 billion; $1.02 billion remained under the program as of Dec. 31, 2024
CleanSpark reported fiscal first-quarter 2025 results for the quarter ended December 31, 2024, with revenue of $162.3 million, up 120% from $73.8 million a year earlier, and net income of $246.8 million, or $0.85 per basic share, compared with $25.9 million, or $0.14, in the prior-year period. The income statement includes a $218.2 million gain on the fair value of bitcoin, and adjusted EBITDA rose to $321.6 million from $69.1 million, which matters to shareholders because the reported profit increase was large relative to the prior year.
Revenue of $162.3 million, up $88.5 million, or 120%, from $73.8 million a year earlier
Net income of $246.8 million, or $0.85 per basic share, versus $25.9 million, or $0.14 per basic share
Adjusted EBITDA of $321.6 million, up from $69.1 million; the company said it closed a $650 million convertible bond
Power Integrations reported fourth-quarter 2024 revenue of $105.2 million, up 18% from a year earlier but down 9% from the prior quarter, with GAAP diluted EPS of $0.16 versus $0.25 a year earlier. For full-year 2024, revenue fell to $419.0 million from $444.5 million and GAAP diluted EPS fell to $0.56 from $0.97. The company guided first-quarter 2025 revenue to be flat with the fourth quarter, plus or minus five percent.
Q4 2024 net revenues were $105.2 million, up 18% year over year and down 9% from Q3 2024.
Q4 2024 GAAP diluted EPS was $0.16 and non-GAAP diluted EPS was $0.30, versus $0.25 and $0.22 a year earlier.
Full-year 2024 net revenues were $419.0 million versus $444.5 million in 2023; GAAP diluted EPS was $0.56 versus $0.97.
Q1 2025 outlook: revenue flat versus Q4 2024 plus or minus 5%; GAAP gross margin 55% to 55.5%.
For the quarter ended December 31, 2024, e.l.f. Beauty reported net sales up 31% to $355.3 million, but GAAP diluted earnings per share fell to $0.30 from $0.46 a year earlier. The company lowered its fiscal 2025 outlook, with net sales now expected at $1,300-1,310 million versus the prior $1,315-1,335 million, and it cited softer than expected trends in January.
Q3 net sales rose 31% to $355.3 million; GAAP net income was $17.3 million versus $26.9 million a year earlier.
Q3 GAAP diluted EPS was $0.30 versus $0.46; adjusted diluted EPS was $0.74, flat with the prior year.
Fiscal 2025 net sales outlook cut to $1,300-1,310 million from $1,315-1,335 million; adjusted EBITDA outlook cut to $289-293 million from $304-308 million.
CFO Mandy Fields said the company is taking a prudent approach to the final fiscal quarter given softer January trends.
Paylocity reported second-quarter fiscal 2025 results for the three months ended December 31, 2024, with total revenue of $377.0 million, up 16% from a year earlier. GAAP net income was $37.5 million, or $0.66 per diluted share, down from $38.1 million, or $0.67, a year earlier, and the company said it increased its revenue and profitability guidance for fiscal 2025.
Total revenue was $377.0 million, up 16%; recurring and other revenue was $347.7 million, up 17%.
GAAP net income was $37.5 million, or $0.66 per diluted share, versus $38.1 million, or $0.67, a year earlier.
Fiscal 2025 total revenue is now expected at $1.558 billion to $1.568 billion; adjusted EBITDA at $542.0 million to $550.0 million.
Long-term debt of $325.0 million reflects borrowings to fund the Airbase acquisition on October 1, 2024.
Qualys reported fourth-quarter 2024 revenue of $159.2 million, up 10% year over year, with GAAP net income of $44.0 million and GAAP diluted EPS of $1.19 versus $1.08 a year earlier. The company also guided 2025 revenue to $645.0 million to $657.0 million (6% to 8% growth) and non-GAAP diluted EPS to $5.50 to $5.90, below the $6.13 reported for 2024, and said it would increase its share repurchase program by $200 million.
Q4 2024 non-GAAP net income was $59.4 million, or $1.60 per diluted share, versus $1.40 a year earlier.
Full-year 2024 revenue was $607.6 million, up 10%, and GAAP net income was $173.7 million, or $4.65 per diluted share.
2025 guidance: full-year GAAP EPS of $3.62 to $4.02 and non-GAAP EPS of $5.50 to $5.90; Q1 2025 revenue of $155.5 million to $158.5 million.
Share repurchase program increased by $200 million; 2024 repurchases of common stock totaled $139.9 million.
Boyd Gaming reported fourth-quarter 2024 revenue of $1.0 billion, up from $954.4 million a year earlier, and net income of $170.5 million, or $1.92 per share, versus $92.6 million, or $0.94 per share, in the prior-year quarter. Full-year 2024 revenue rose to $3.9 billion, but full-year net income of $578.0 million was below $620.0 million in 2023, although diluted EPS was $6.19 compared with $6.12. The filing furnishes the earnings press release as Exhibit 99.1 and does not include forward guidance.
Q4 2024 adjusted earnings were $174.7 million, or $1.96 per share, compared with $163.8 million, or $1.66 per share, in Q4 2023.
Full-year 2024 adjusted earnings were $611.3 million, or $6.55 per share, versus $639.9 million, or $6.31 per share, in 2023.
The company repurchased $203 million of its shares in Q4 2024 and had about $640 million remaining under current authorizations as of December 31, 2024.
Prior-year Q4 results included $103.3 million in non-cash impairment charges.
StepStone reported results for the quarter ended December 31, 2024, with total revenues of $339.0 million, compared with negative $14.6 million a year earlier. The GAAP net loss attributable to StepStone widened to $192.0 million, or $2.61 per diluted share, as equity-based compensation rose to $486.4 million, while non-GAAP measures such as fee-related earnings and adjusted net income grew, and the board declared a $0.24 quarterly dividend.
GAAP net loss attributable to StepStone was $192.0 million, or $2.61 per diluted share, versus a loss of $20.2 million, or $0.32 per share, a year earlier.
Equity-based compensation was $486.4 million, compared with $14.0 million in the prior-year quarter.
Adjusted revenues were $243.9 million, up 32%; fee-related earnings were $74.1 million, up 46%; ANI per share was $0.44 versus $0.37.
Board declared a $0.24 per share quarterly dividend, payable March 14, 2025, to holders of record on February 28, 2025.
First Bancorp (FBNC) said Adam Currie, previously President of First Bank, becomes CEO of the bank effective February 7, 2025, succeeding Michael G. Mayer, who remains President of the company. The company also authorized a stock repurchase plan of up to $40.0 million of its common stock, which the filing says may be modified or discontinued at any time.
Adam Currie appointed President and CEO of First Bank, effective February 7, 2025
Michael G. Mayer relinquishes bank CEO role and remains President of First Bancorp; release says until early 2026
Board authorized repurchases of up to $40.0 million of common stock; no minimum amount required
Christian Wilson, EVP and Chief Operating Officer, signed a new employment agreement effective February 7, 2025
GATX agreed under an underwriting agreement dated February 4, 2025 to sell $500 million of 5.500% Senior Notes due 2035 and $300 million of 6.050% Senior Notes due 2054, with delivery against payment on February 6, 2025. The 2054 notes will form a single series with $400 million issued June 5, 2024, bringing the total outstanding 2054 notes to $700 million, which adds to the company's debt load.
$500 million of 5.500% Senior Notes due 2035 offered
$300 million of 6.050% Senior Notes due 2054 offered, fungible with $400 million issued June 5, 2024
Aggregate 2054 notes outstanding to total $700 million on completion
Notes issued under a 2008 indenture with U.S. Bank Trust Company, National Association, as trustee
Exponent reported fourth-quarter 2024 total revenues of $136.8 million, up 11.3%, and net income of $23.6 million, or $0.46 per diluted share, versus $0.41 a year earlier. The company also raised its quarterly cash dividend from $0.28 to $0.30 per share and guided to first-quarter 2025 revenues down in the low-single digits and full-year 2025 revenues growing in the low-single digits.
Q4 2024 total revenues rose 11.3% to $136.8 million; net income rose to $23.6 million, or $0.46 per diluted share, from $20.9 million, or $0.41
Quarterly dividend increased from $0.28 to $0.30 per share, payable March 21, 2025 to holders of record as of March 7, 2025
Q1 2025 guidance: revenues before reimbursements down in the low-single digits; EBITDA 25.0% to 26.0% of revenues before reimbursements
Full-year 2025 guidance: revenues before reimbursements to grow in the low-single digits; EBITDA 26.25% to 27.0%
Neurocrine Biosciences reported fourth-quarter 2024 total revenues of $627.7 million, up from $515.2 million a year earlier, driven by INGREZZA net product sales of $615 million. GAAP net income fell to $103.1 million, or $1.00 per diluted share, from $147.7 million, or $1.44, as operating expenses rose, while non-GAAP diluted EPS rose to $1.69 from $1.54. The company also issued full-year 2025 INGREZZA net product sales guidance of $2.5 billion to $2.6 billion.
Q4 2024 total revenues $627.7 million vs. $515.2 million in Q4 2023; full-year 2024 total revenues $2,355.3 million vs. $1,887.1 million
Q4 2024 GAAP diluted EPS $1.00 vs. $1.44; non-GAAP diluted EPS $1.69 vs. $1.54, with the company citing $28 million of higher stock-based compensation tied to CRENESSITY approval and the CEO retirement charge
CRENESSITY fourth-quarter 2024 net product sales were $2 million, reflecting initial pharmacy orders after FDA approval in December 2024
Full-year 2025 guidance: INGREZZA net product sales of $2.5 billion to $2.6 billion; non-GAAP R&D of $890 million to $940 million and non-GAAP SG&A of $955 million to $975 million
Doximity reported fiscal third-quarter 2025 results for the quarter ended December 31, 2024, with revenue of $168.6 million, up 25% year over year, and net income of $75.2 million, up from $48.0 million. The company also issued fourth-quarter guidance of $132.5 million to $133.5 million in revenue and updated its fiscal 2025 revenue guidance to $564.6 million to $565.6 million.
Q3 revenue of $168.6 million versus $135.3 million a year earlier, up 25%
Diluted net income per share of $0.37 versus $0.24; adjusted EBITDA of $102.0 million, up 39%
Q4 guidance: revenue of $132.5 million to $133.5 million; adjusted EBITDA of $62.5 million to $63.5 million
Fiscal 2025 guidance updated to revenue of $564.6 million to $565.6 million and adjusted EBITDA of $306.6 million to $307.6 million
Frontdoor, Inc. disclosed that director Lara H. Balazs notified the board on February 5, 2025, that she will not stand for re-election when her term expires at the 2025 annual stockholders meeting. The company said the decision is not due to any disagreement with Frontdoor on its operations, policies or practices. The filing does not name a successor or describe any change to financial results.
Director Lara H. Balazs notified the board on February 5, 2025.
Her term expires at the Company's 2025 annual meeting of stockholders.
Company states the decision is not due to any disagreement on operations, policies or practices.
Expedia Group reported fourth-quarter 2024 revenue of $3.2 billion, up 10% from a year earlier, and gross bookings of $24.4 billion, up 13%. GAAP net income attributable to stockholders more than doubled to $299 million, and the board's Executive Committee declared a $0.40 quarterly dividend, reinstating a payout suspended in 2020 that shareholders will receive if they are on record by March 6, 2025.
Q4 2024 gross bookings were $24.4 billion, up 13%, and booked room nights were 86.4 million, up 12%.
Q4 2024 net income attributable to Expedia Group stockholders was $299 million, versus $132 million; diluted EPS was $2.20, versus $0.92.
Quarterly dividend of $0.40 per share: record date March 6, 2025; payable March 27, 2025.
In 2024, the company repurchased over 12 million shares for $1.6 billion.
Monolithic Power Systems reported fourth-quarter 2024 revenue of $621.7 million, up 36.9% from $454.0 million a year earlier, and non-GAAP diluted earnings of $4.09 per share, up from $2.88. GAAP diluted EPS of $29.88 was inflated by a $1.3 billion tax benefit from a foreign subsidiary. The board raised the quarterly dividend to $1.56 per share from $1.25 and approved a $500 million stock repurchase program that expires February 4, 2028.
Q4 2024 revenue of $621.7 million compared with $454.0 million a year earlier and $620.1 million in the prior quarter.
GAAP net income of $1.4 billion ($29.88 per diluted share) included a $1.3 billion tax benefit; non-GAAP net income was $198.4 million ($4.09 per diluted share).
First-quarter 2025 revenue outlook is $610.0 million to $630.0 million.
Dividend of $1.56 per share payable April 15, 2025 to holders of record as of March 31, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.